Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of cetirizine hydrochloride injection for acute urticaria
CTR20250059Phase 3Active
- Sponsor
- Beijing Zhongfu Pharmaceutical
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cetirizine in acute urticaria, sponsored by Beijing Zhongfu Pharmaceutical. Started Jan 2025; status: active.
02
Drugs
cetirizine
03
Conditions
acute urticaria
Beyond the preview
Go deeper on CTR20250059.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20250059.